Talon Therapeutics (NASDAQOTCBB:TLON)

CAPS Rating: 1 out of 5

A development stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care.

Recs

0
Player Avatar pchop123 (76.60) Submitted: 8/11/2012 7:01:54 PM : Underperform Start Price: $1.09 TLON Score: +21.19

this stock has been diluted with warrants & preferreds

Featured Broker Partners


Advertisement